Tom Van Loy

Dr. Tom Van Loy

Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, KU Leuven, 3000 Leuven, Belgium
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2002 in Peptides
Verified
Journal Article
Closed access
ICIlse Claeys
Ilse Claeys
GSGert Simonet
Gert Simonet
JPJeroen Poels
Jeroen Poels
Tom Van LoyTom Van Loy
Tom Van Loy
LVLinda Vercammen
Linda Vercammen
JBJozef Vanden Broeck
Jozef Vanden Broeck

17 March 2005 in FEBS Letters
Verified
Journal Article
Closed access
FMFernando M. Mendive
Fernando M. Mendive
Tom Van LoyTom Van Loy
Tom Van Loy
Sylvie ClaeysenSylvie Claeysen
Sylvie Claeysen
JPJeroen Poels
Jeroen Poels
MWMichael Williamson
Michael Williamson
JBJozef Vanden Broeck
Jozef Vanden Broeck

21 April 2011 in EMBO Reports
Verified
Journal Article
Open access
PDF file
RMRoxana C Mustata
Roxana C Mustata
Tom Van LoyTom Van Loy
Tom Van Loy
ALAnne Lefort
Anne Lefort
FLFrédérick Libert
Frédérick Libert
SSSandra Strollo
Sandra Strollo
MGMarie‐Isabelle Garcia
Marie‐Isabelle Garcia
Gene inactivation of the orphan G protein‐coupled receptor LGR4, a paralogue of the epithelial‐stem‐cell marker LGR5, results in a 50% decrease in epithelial cell proliferation and an 80% reduction in terminal differentiation of Paneth cells in postnatal mouse intestinal crypts. When cultured ex vivo , LGR4‐deficient crypts or progenitors, but not LGR5‐deficient progenitors , die rapidly with marked downregulation of stem‐cell markers and Wnt target genes, including Lgr5 . Partial rescue of this phenotype is achieved by addition of LiCl to the culture medium, but not Wnt agonists. Our results identify LGR4 as a permissive factor in the Wnt pathway in the intestine and, as such, as a potential target for intestinal cancer therapy. There is a [Hot off the Press][1] (June 2011) associated with this Scientific Report. [1]: http://dx.doi.org/10.1038/embor.2011.97

1 August 2007 in General and Comparative Endocrinology
Verified
Journal Article
Closed access
LBLiesbeth Badisco
Liesbeth Badisco
ICIlse Claeys
Ilse Claeys
Tom Van LoyTom Van Loy
Tom Van Loy
MHMatthias Van Hiel
Matthias Van Hiel
VFVanessa Franssens
Vanessa Franssens
JBJozef Vanden Broeck
Jozef Vanden Broeck

11 May 2010 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
JPJeroen Poels
Jeroen Poels
Tom Van LoyTom Van Loy
Tom Van Loy
HVHans Peter Vandersmissen
Hans Peter Vandersmissen
BHBoris Van Hiel
Boris Van Hiel
SSSofie Van Soest
Sofie Van Soest
JBJozef Vanden Broeck
Jozef Vanden Broeck

1 March 2010 in Peptides
Verified
Journal Article
Closed access
Tom Van LoyTom Van Loy
Tom Van Loy
HVHans Peter Vandersmissen
Hans Peter Vandersmissen
JPJeroen Poels
Jeroen Poels
MHMatthias B. Van Hiel
Matthias B. Van Hiel
HVHeleen Verlinden
Heleen Verlinden
JBJozef Vanden Broeck
Jozef Vanden Broeck